SCHEMBL670404

SCHEMBL670404

CCOC(=O)c1cccc(Br)c1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.58
ALDH1A1 P00352 2/20 0.50
HSD17B10 Q99714 2/20 0.50
KMT2A Q03164 2/20 0.49
MAPT P10636 2/20 0.49
MEN1 O00255 1/20 0.49
USP2 O75604 1/20 0.49
ALOX15 P16050 1/20 0.49
CDC25B P30305 3/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
POLB P06746 1/20 0.46
KDM4E B2RXH2 3/20 0.45
HPGD P15428 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23773427 0.88 TSHR (0.68) TSHRALDH1A1HSD17B10KMT2AMAPT
SCHEMBL11678098 0.85 TSHR (0.63) TSHRALDH1A1HSD17B10KMT2AMAPT
SCHEMBL6692010 0.84 TSHR (0.54) TSHRALDH1A1HSD17B10KMT2AMAPT
SCHEMBL4800372 0.83 TSHR (0.40) TSHRALDH1A1HSD17B10KMT2AMAPT
SCHEMBL184184 0.83 LMNA (0.48) TSHRALDH1A1HSD17B10KMT2AMEN1
SCHEMBL7688461 0.82 KMT2A (0.65) TSHRALDH1A1HSD17B10KMT2AMAPT
SCHEMBL29196257 0.82 TSHR (0.59) TSHRALDH1A1HSD17B10KMT2AMAPT
SCHEMBL21612146 0.82 TSHR (0.59) TSHRALDH1A1HSD17B10KMT2AMAPT
SCHEMBL30604539 0.82 TSHR (0.59) TSHRALDH1A1HSD17B10KMT2AMAPT
SCHEMBL6692105 0.82 TSHR (0.51) TSHRALDH1A1HSD17B10KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9849109-B2 Autotaxin inhibitors and uses thereof AMIRA PHARMACEUTICALS, INC. (US) 2017-12-26 US disclosed
EP-2606031-B1 AUTOTAXIN INHIBITORS AND USES THEREOF AMIRA PHARMACEUTICALS INC (US) 2017-09-27 EP disclosed
US-20150164861-A1 AUTOTAXIN INHIBITORS AND USES THEREOF AMIRA PHARMACEUTICALS, INC. (US) 2015-06-18 US disclosed
US-9000025-B2 Autotaxin inhibitors and uses thereof AMIRA PHARMACEUTICALS, INC. (US) 2015-04-07 US disclosed
EP-2606031-A2 AUTOTAXIN INHIBITORS AND USES THEREOF Amira Pharmaceuticals, Inc. (US) 2013-06-26 EP disclosed
US-20130150326-A1 AUTOTAXIN INHIBITORS AND USES THEREOF AMIRA PHARMACEUTICALS, INC. (US) 2013-06-13 US disclosed
WO-2012024620-A2 AUTOTAXIN INHIBITORS AND USES THEREOF AMIRA PHARMACEUTICALS, INC. (US) 2012-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150326-A1 AUTOTAXIN INHIBITORS AND USES THEREOF ENPP2, SERPINB1, SERPINE1 TSHR 2622/4885ALDH1A1 4786/4885HSD17B10 3308/4885
US-20150164861-A1 AUTOTAXIN INHIBITORS AND USES THEREOF ENPP2, SERPINB1, SERPINE1 TSHR 2622/4885ALDH1A1 4786/4885HSD17B10 3308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.